Who
Joy Liu
EVP and Chief Legal Officer
Company insider
Files Form 4 as: EVP and Chief Legal Officer, Vertex Pharmaceuticals.
In numbers
- Trades disclosed
- 42
- Buys
- 0
- Sells
- 12
- Bought
- $0
- Sold
- $6.9M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 5 Mar 2021
- Last trade
- 1 Jul 2026
- Last filed
- 6 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jul 2026filed 6 Jul 2026 | VRTX Vertex PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $416K828 at $502.71 | filing |
| 1 Jul 2026filed 6 Jul 2026 | VRTX Vertex PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $416K828 at $502.71 | filing |
| 1 Jun 2026filed 3 Jun 2026 | VRTX Vertex PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $364K828 at $439.91 | filing |
| 1 Jun 2026filed 3 Jun 2026 | VRTX Vertex PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $364K828 at $439.91 | filing |
| 1 May 2026filed 5 May 2026 | VRTX Vertex PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $469K1,104 at $425.02 | filing |
| 1 May 2026filed 5 May 2026 | VRTX Vertex PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $469K1,104 at $425.02 | filing |
| 1 Apr 2026filed 3 Apr 2026 | VRTX Vertex PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $439K978 at $449.17 | filing |
| 1 Apr 2026filed 3 Apr 2026 | VRTX Vertex PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $439K978 at $449.17 | filing |
| 2 Mar 2026filed 4 Mar 2026 | VRTX Vertex PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $442K892 at $495.96 | filing |
| 2 Mar 2026filed 4 Mar 2026 | VRTX Vertex PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $442K892 at $495.96 | filing |
| 15 Aug 2022filed 17 Aug 2022 | VRTX Vertex PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $62K206 at $300.26 | filing |
| 15 Aug 2022filed 17 Aug 2022 | VRTX Vertex PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $211K698 at $301.63 | filing |
| 15 Aug 2022filed 17 Aug 2022 | VRTX Vertex PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $30K100 at $302.35 | filing |
| 15 Aug 2022filed 17 Aug 2022 | VRTX Vertex PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $213K700 at $303.99 | filing |
| 15 Aug 2022filed 17 Aug 2022 | VRTX Vertex PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $532K1,743 at $305.01 | filing |
| 15 Aug 2022filed 17 Aug 2022 | VRTX Vertex PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $92K300 at $305.57 | filing |
| 10 Aug 2022filed 12 Aug 2022 | VRTX Vertex PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $11K36 at $300.32 | filing |
| 9 Aug 2022filed 10 Aug 2022 | VRTX Vertex PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $284K946 at $300.00 | filing |
| 16 May 2022filed 18 May 2022 | VRTX Vertex PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $6,26925 at $250.77 | filing |
| 16 May 2022filed 18 May 2022 | VRTX Vertex PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $4,78019 at $251.57 | filing |
News
Head to Head Analysis: Caribou Biosciences (NASDAQ:CRBU) & Vertex Pharmaceuticals (NASDAQ:VRTX)VRTX · tickerreport.com · 14 Oct 2026Vertex Pharmaceuticals Incorporated: Vertex to Present New Data on ALYFTREK at the North American Cystic Fibrosis ConferenceVRTX · finanznachrichten.de · 9 Oct 2026
0 headlines in the last 90 days name Joy Liu; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.